Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites

Journal of Infectious Diseases

Volumn 195, Issue 7, 2007, Pages 927-933

  Imwong, Mallika ^a   Snounou, Georges ^d   Pukrittayakamee, Sasithon ^a,b   Tanomsing, Naowarat ^a   Jung, Ryong Kim ^a,f   Nandy, Amitab ^f   Guthmann, Jean Paul ^e   Nosten, Francois ^a,c,g   Carlton, Jane ^h,j   Looareesuwan, Sornchai ^a   Nair, Shalini ⁱ   Sudimack, Daniel ⁱ   Day, Nicholas P J ^a,g   Anderson, Timothy J C ⁱ   White, Nicholas J ^a,g  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Royal Institute   (Thailand)

^c SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^d MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^e EPICENTRE   (France)

^f CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^g CHURCHILL HOSPITAL   (United Kingdom)

^h J CRAIG VENTER INSTITUTE   (United States)

ⁱ SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^j NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; ARTESUNATE; CHLOROQUINE; HALOFANTRINE; PRIMAQUINE; QUININE SULFATE;

ARTICLE; BLOOD SAMPLING; FEMALE; GENOTYPE; HUMAN; HYPNOZOITE; INDIA; MAJOR CLINICAL STUDY; MALARIA; MALE; MYANMAR; NONHUMAN; PARASITEMIA; PLASMODIUM VIVAX; PRIMARY INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION; REINFECTION; RELAPSE; SPOROZOON; THAILAND; TREATMENT DURATION;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHILD; CHLOROQUINE; DNA PRIMERS; HUMANS; INDIA; MALARIA, VIVAX; MYANMAR; PLASMODIUM VIVAX; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRIMAQUINE; PROTOZOAN PROTEINS; RECURRENCE; THAILAND; TREATMENT OUTCOME;

EID: 33947431664     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/512241     Document Type: Article

References (31)

1. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001; 64:97-106.
2. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 2004; 4:327-36.
3. Baird JK, Basri H, Purnomo, et al. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 1991; 44: 547-52.
4. Garavelli PL, Corti E. Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Trans R Soc Trop Med Hyg 1992; 86:128.
5. Myat Phone K, Myint O, Myint L, Thaw Z, Kyin Hla A, Nwe Nwe Y. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans R Soc Trop Med Hyg 1993; 87:687.
6. Murphy GS, Basri H, Purnomo, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 1993; 341:96-100.
7. Garg M, Gopinathan N, Bodhe P, Kshirsagar NA. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg 1995; 89:656-7.
8. Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BM, Coleman RE, Sattabongkot J. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother 2003; 47:170-3.
9. Pukrittayakamee S, Chantra A, Simpson JA, et al. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob Agents Chemother 2000; 44:1680-5.
10. Imwong M, Pukrittakayamee S, Looareesuwan S, et al. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob Agents Chemother 2001; 45:3122-7.
11. Imwong M, Pukrittayakamee S, Renia L, et al. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob Agents Chemother 2003; 47:1514-21.
12. Snounou G, Beck H. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial treatment. Parasitology Today 1998; 14:462-7.
13. Brockman A, Paul RE, Anderson TJ, et al. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg 1999; 60:14-21.
14. Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey G. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg 2003; 68:133-9.
15. Ohrt C, Mirabelli-Primdahl L, Karnasuta C, Chantakulkij S, Kain KC. Distinguishing Plasmodium falciparum treatment failures from reinfections by restrictions fragment length polymorphism and polymerase chain reaction genotyping. Am J Trop Med Hyg 1997; 57:430-7.
16. Craig A, Kain K. Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. J Infect Dis 1996; 174:373-9.
17. Kirchgatter K, del Portillo HA. Molecular analysis of Plasmodium vivax relapses using the MSP1 molecule as a genetic marker. J Infect Dis 1998; 177:511-5.
18. Khusmith S. Antigenic disparity of Plasmodium vivax causing initial symptoms and causing relapse. Southeast Asian J Trop Med Public Health 1998; 29:519-24.
19. Imwong M, Pukrittayakamee S, Gruner AC, et al. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J 2005; 4:20.
20. Bruce MC, Galinski MR, Barnwell JW, Snounou G, Day KP. Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity. Am J Trop Med Hyg 1999; 61:518-25.
21. Gomez JC. Identification of a polymorphic Plasmodium vivax microsatellite marker. Am J Trop Med Hyg 2003; 69:377-9.
22. Leclerc MC. Meager genetic variability of the human malaria agent Plasmodium vivax. Proc Natl Acad Sci USA 2004; 101:14455-60.
23. Pukrittayakamee S, Imwong M, Looareesuwan S, White NJ. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop 2004; 89:351-6.
24. Silachamroon U, Krudsood S, Treeprasertsuk S, et al. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg 2003; 69:14-8.
25. Snounou G, Singh B. Nested PCR analysis of Plasmodium parasites. Methods Mol Med 2002; 72:189-203.
26. The Institute for Genome Research. Plasmodium vivax genome project. Available at: http://www.tigr.org/tdb/e2k1/pva1/. Accessed 8 February 2007.
27. Benson G. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res 1999; 27:573-80.
28. Tandem Repeats Finder program. Available at: http://tandem.bu.edu/trf/ trf.html. Accessed 8 February 2007.
29. Tandem Repeats Finder. Available at: http://frodo.wi.mit.edu/cgi-bin/ primer3/primer3.cgi. Accessed 8 February 2007.
30. White NJ. The assessment of antimalarial drug efficacy. Trends Parasitol 2002; 18:458-64.
31. Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q. Relapses of Pladmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis 2007; 195:934-41 (in this issue).